- £2.54bn
- £2.23bn
- £2.03bn
- 85
- 12
- 99
- 75
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 772 | 1,163 | 1,735 | 1,975 | 2,030 |
Cost of Revenue | |||||
Gross Profit | 189 | 348 | 495 | 643 | 726 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,092 | 1,372 | 2,025 | 2,220 | 2,074 |
Operating Profit | -320 | -209 | -290 | -246 | -43.7 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -318 | -213 | -282 | -231 | -10.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -317 | -208 | -289 | -243 | -18.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -317 | -226 | -331 | -294 | -31.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -317 | -226 | -331 | -294 | -31.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.17 | -0.102 | -0.154 | -0.105 | -0.014 |
Dividends per Share |